[Adverse effects of DMARDs in treatment of rheumatoid arthritis].
Sugii
Shoji
S
Department of Rehabilitation, National Hospital Organization Sagamihara National Hospital.
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006052:Gold Sodium Thiomalate / Q000009:adverse effects; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced; D000077339:Leflunomide; D017563:Lung Diseases, Interstitial / Q000139:chemically induced; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D012098:Reproduction / Q000187:drug effects; D012460:Sulfasalazine / Q000009:adverse effects
D018501:Antirheumatic Agents; D007555:Isoxazoles; D006052:Gold Sodium Thiomalate; D012460:Sulfasalazine; D000077339:Leflunomide; D008727:Methotrexate